Exploring the effects of isothiocyanates on chemotherapeutic drugs

Bibliography

• WHO. Cancer Fact Sheet N° 297. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/ [Last accessed 28 July 2013]
   Google Scholar
• Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000;21:525-30
   PubMed Web of Science ®Google Scholar
• Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 2007;55:224-36
   PubMed Web of Science ®Google Scholar
• Sonderby IE, Geu-Flores F, Halkier BA. Biosynthesis of glucosinolates–gene discovery and beyond. Trends Plant Sci 2010;15:283-90
   PubMed Web of Science ®Google Scholar
• Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001;56:5-51
   PubMed Web of Science ®Google Scholar
• Fahey JW, Wehage SL, Holtzclaw WD, et al. Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prev Res (Phila) 2012;5:603-11
   PubMed Web of Science ®Google Scholar
• Lamy E, Scholtes C, Herz C, Mersch-Sundermann V. Pharmacokinetics and pharmacodynamics of isothiocyanates. Drug Metab Rev 2011;43:387-407
   PubMed Web of Science ®Google Scholar
• Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 2008;269:291-304
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li YW. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin 2007;28:1305-15
   PubMed Web of Science ®Google Scholar
• Shapiro TA, Fahey JW, Dinkova-Kostova AT, et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer 2006;55:53-62
   PubMed Web of Science ®Google Scholar
• Ji Y, Morris ME. Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry. Anal Biochem 2003;323:39-47
   PubMed Web of Science ®Google Scholar
• Gasper AV, Al-Janobi A, Smith JA, et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 2005;82:1283-91
   PubMed Web of Science ®Google Scholar
• Zhang Y. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 2001;22:425-31
   PubMed Web of Science ®Google Scholar
• Zhang Y, Callaway EC. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J 2002;364:301-7
   PubMed Web of Science ®Google Scholar
• Kerr I, Simpkins NS. ABC transporters and ITC. Lett Drug Des Discov 2006;3:607-21
   Web of Science ®Google Scholar
• Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 2000;32:395-411
   PubMed Web of Science ®Google Scholar
• Kensler TW, Ng D, Carmella SG, et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis 2012;33:101-7
   PubMed Web of Science ®Google Scholar
• Tseng E, Scott-Ramsay EA, Morris ME. Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines. Exp Biol Med (Maywood) 2004;229:835-42
   PubMed Web of Science ®Google Scholar
• Hsu YC, Chang SJ, Wang MY, et al. Growth inhibition and apoptosis of neuroblastoma cells through ROS-independent MEK/ERK activation by sulforaphane. Cell Biochem Biophys 2013
   Web of Science ®Google Scholar
• Xu K, Thornalley PJ. Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. Biochem Pharmacol 2000;60:221-31
   PubMed Web of Science ®Google Scholar
• Xu C, Shen G, Yuan X, et al. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 2006;27:437-45
   PubMed Web of Science ®Google Scholar
• Mi L, Wang X, Govind S, et al. The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res 2007;67:6409-16
   PubMed Web of Science ®Google Scholar
• Chen MJ, Tang WY, Hsu CW, et al. Apoptosis induction in primary human colorectal cancer cell lines and retarded tumor growth in SCID mice by sulforaphane. Evid Based Complement Alternat Med 2012;2012:415231
   PubMedGoogle Scholar
• Wu X, Zhou QH, Xu K. Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin 2009;30:501-12
   PubMed Web of Science ®Google Scholar
• Conaway CC, Yang YM, Chung FL. Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 2002;3:233-55
   PubMed Web of Science ®Google Scholar
• Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009;34:176-88
   PubMed Web of Science ®Google Scholar
• Payen L, Courtois A, Loewert M, et al. Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochem Biophys Res Commun 2001;282:257-63
   PubMed Web of Science ®Google Scholar
• Kalra S, Zhang Y, Knatko EV, et al. Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway. Cancer Prevent Res 2011;4:1665-74
   PubMed Web of Science ®Google Scholar
• Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 2001;167:73-81
   PubMed Web of Science ®Google Scholar
• Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006;6:135-45
   PubMed Web of Science ®Google Scholar
• Hwang ES, Lee HJ. Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. Int J Food Sci Nutr 2010;61:324-36
   PubMed Web of Science ®Google Scholar
• Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Mol Cancer Ther 2007;6:1673-81
   PubMed Web of Science ®Google Scholar
• Shen G, Xu C, Chen C, et al. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother Pharmacol 2006;57:317-27
   PubMed Web of Science ®Google Scholar
• Singh SV, Srivastava SK, Choi S, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005;280:19911-24
   PubMed Web of Science ®Google Scholar
• Mi L, Di Pasqua AJ, Chung FL. Proteins as binding targets of isothiocyanates in cancer prevention. Carcinogenesis 2011;32:1405-13
   PubMed Web of Science ®Google Scholar
• Cavell BE, Syed Alwi SS, Donlevy A, Packham G. Anti-angiogenic effects of dietary isothiocyanates: mechanisms of action and implications for human health. Biochem Pharmacol 2011;81:327-36
   PubMed Web of Science ®Google Scholar
• Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004;64:5767-74
   PubMed Web of Science ®Google Scholar
• Singh SV, Singh K. Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. Carcinogenesis 2012;33:1833-42
   PubMed Web of Science ®Google Scholar
• Navarro SL, Li F, Lampe JW. Mechanisms of action of isothiocyanates in cancer chemoprevention: an update. Food Funct 2011;2:579-87
   PubMed Web of Science ®Google Scholar
• Zhang YS. The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. Carcinogenesis 2012;33:2-9
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Kostov RV. Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 2012;18:337-47
   PubMed Web of Science ®Google Scholar
• Powolny A, Bommareddy A, Singh S. Slow but steady progress in cancer chemoprevention with phenethyl isothiocyanate: fulfilled promises and translational challenges. In: Sarkar FH, editor. Nutraceuticals and cancer. Springer Science+Business Media; Germany: 2012. p. 231-58
   Google Scholar
• Zhang Y. Allyl isothiocyanate as a cancer chemopreventive phytochemical. Mol Nutr Food Res 2010;54:127-35
   PubMed Web of Science ®Google Scholar
• Clarke JD, Hsu A, Yu Z, et al. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res 2011;55:999-1009
   PubMed Web of Science ®Google Scholar
• Wang X, Doherty GP, Leith MK, et al. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. Br J Cancer 1999;80:1223-30
   PubMed Web of Science ®Google Scholar
• Rockwell S, Sartorelli AC, Tomasz M, Kennedy KA. Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev 1993;12:165-76
   PubMed Web of Science ®Google Scholar
• Digby T, Leith MK, Thliveris JA, Begleiter A. Effect of NQ01 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. Cancer Chemother Pharmacol 2005;56:307-16
   PubMed Web of Science ®Google Scholar
• Tseng E, Kamath A, Morris ME. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. Pharm Res 2002;19:1509-15
   PubMed Web of Science ®Google Scholar
• Ji Y, Morris ME. Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport. Pharm Res 2004;21:2261-9
   PubMed Web of Science ®Google Scholar
• Liebes L, Conaway CC, Hochster H, et al. High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal Biochem 2001;291:279-89
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-41
   PubMed Web of Science ®Google Scholar
• Thorn CF, Oshiro C, Marsh S, et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 2011;21:440-6
   PubMed Web of Science ®Google Scholar
• Zanichelli F, Capasso S, Di Bernardo G, et al. Low concentrations of isothiocyanates protect mesenchymal stem cells from oxidative injuries, while high concentrations exacerbate DNA damage. Apoptosis 2012;17:964-74
   PubMed Web of Science ®Google Scholar
• Fimognari C, Lenzi M, Sestili P, et al. Sulforaphane potentiates RNA damage induced by different xenobiotics. PLoS One 2012;7:e35267
   PubMedGoogle Scholar
• Ravi D, Das KC. Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage. Cancer Chemother Pharmacol 2004;54:449-58
   PubMed Web of Science ®Google Scholar
• Fimognari C, Nusse M, Lenzi M, et al. Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations. Mutat Res 2006;601:92-101
   PubMed Web of Science ®Google Scholar
• Fimognari C, Lenzi M, Sciuscio D, et al. Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation. Ann NY Acad Sci 2007;1095:62-9
   PubMed Web of Science ®Google Scholar
• Geisler S, Lonning PE, Aas T, et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res 2001;61:2505-12
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Dey S, Bhattacharya RK, Roy M. Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol Cell Biochem 2009;330:9-22
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006;5:577-84
   PubMed Web of Science ®Google Scholar
• Kim YW, Hur SY, Kim TE, et al. Protein kinase C modulates telomerase activity in human cervical cancer cells. Exp Mol Med 2001;33:156-63
   PubMed Web of Science ®Google Scholar
• Chang JT, Lu YC, Chen YJ, et al. hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells. Br J Cancer 2006;94:870-8
   PubMedGoogle Scholar
• Mukherjee S, Bhattacharya RK, Roy M. Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. J Environ Pathol Toxicol Oncol 2009;28:269-82
   PubMed Web of Science ®Google Scholar
• Jakubikova J, Cervi D, Ooi M, et al. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 2011;96:1170-9
   PubMed Web of Science ®Google Scholar
• Baldwin EL, Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents 2005;5:363-72
   PubMedGoogle Scholar
• Trachootham D, Zhang H, Zhang W, et al. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 2008;112:1912-22
   PubMed Web of Science ®Google Scholar
• Garcia-Manero G, Yang H, Bueso-Ramos C, et al. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood 2008;111:1060-6
   PubMed Web of Science ®Google Scholar
• Hu Y, Lu W, Chen G, et al. Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound beta-phenylethyl isothiocyanate. Blood 2010;116:2732-41
   PubMed Web of Science ®Google Scholar
• Ibrahim N, Yu Y, Walsh WR, Yang JL. Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review). Oncol Rep 2012;27:1303-11
   PubMed Web of Science ®Google Scholar
• Ebos JM, Lee CR, Cruz-Munoz W, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009;15:232-9
   PubMed Web of Science ®Google Scholar
• Kallifatidis G, Rausch V, Baumann B, et al. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 2009;58:949-63
   PubMed Web of Science ®Google Scholar
• Rausch V, Liu L, Kallifatidis G, et al. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res 2010;70:5004-13
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng B. In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma. BMC Cancer 2007;7:95
   PubMedGoogle Scholar
• Wang XF, Wu DM, Li BX, et al. Synergistic inhibitory effect of sulforaphane and 5-fluorouracil in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. Phytother Res 2009;23:303-7
   PubMed Web of Science ®Google Scholar
• Milczarek M, Misiewicz-Krzeminska I, Lubelska K, Wiktorska K. Combination treatment with 5-fluorouracil and isothiocyanates shows an antagonistic effect in Chinese hamster fibroblast cells line-V79. Acta Pol Pharm 2011;68:331-42
   PubMed Web of Science ®Google Scholar
• Mutch DG, Bloss JD. Gemcitabine in cervical cancer. Gynecol Oncol 2003;90:S8-15
   PubMed Web of Science ®Google Scholar
• Park SY, Kim GY, Bae SJ, et al. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep 2007;18:181-7
   PubMed Web of Science ®Google Scholar
• Sharma C, Sadrieh L, Priyani A, et al. Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol 2011;35:272-8
   PubMed Web of Science ®Google Scholar
• Pantschenko AG, Pushkar I, Anderson KH, et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003;23:269-84
   PubMed Web of Science ®Google Scholar
• Kallifatidis G, Labsch S, Rausch V, et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther 2011;19:188-95
   PubMed Web of Science ®Google Scholar
• Dontu G, Jackson KW, McNicholas E, et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 2004;6:R605-15
   PubMed Web of Science ®Google Scholar
• Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008;3:237-46
   PubMed Web of Science ®Google Scholar
• Raymond E, Faivre S, Chaney S, et al. Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 2002;1:227-35
   PubMed Web of Science ®Google Scholar
• Kaminski BM, Weigert A, Brune B, et al. Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death. Cancer Chemother Pharmacol 2011;67:1167-78
   PubMed Web of Science ®Google Scholar
• Tang HL, Yuen KL, Tang HM, Fung MC. Reversibility of apoptosis in cancer cells. Br J Cancer 2009;100:118-22
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22:7265-79
   PubMed Web of Science ®Google Scholar
• Wang X, Govind S, Sajankila SP, et al. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res 2011;55:1572-81
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim YJ, Choi YJ, et al. Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells. Food Chem Toxicol 2012;50:2397-406
   PubMed Web of Science ®Google Scholar
• Di Pasqua AJ, Hong C, Wu MY, et al. Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates. Chem Res Toxicol 2010;23:1307-9
   PubMed Web of Science ®Google Scholar
• Petrylak DP. New paradigms for advanced prostate cancer. Rev Urol 2007;9(Suppl 2):S3-S12
   PubMedGoogle Scholar
• Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004;4:253-65
   PubMed Web of Science ®Google Scholar
• Ganansia-Leymarie V, Bischoff P, Bergerat JP, Holl V. Signal transduction pathways of taxanes-induced apoptosis. Curr Med Chem Anticancer Agents 2003;3:291-306
   PubMedGoogle Scholar
• Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics 2011;3:503-18
   PubMed Web of Science ®Google Scholar
• Xiao D, Singh SV. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res 2002;62:3615-19
   PubMed Web of Science ®Google Scholar
• Liu K, Cang S, Ma Y, Chiao JW. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int 2013;13:10
   PubMed Web of Science ®Google Scholar
• Xiao D, Singh SV. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo. Pharm Res 2010;27:722-31
   PubMed Web of Science ®Google Scholar
• Rattan R, Giri S, Hartmann LC, Shridhar V. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med 2011;15:166-78
   PubMed Web of Science ®Google Scholar
• Xiao D, Powolny AA, Moura MB, et al. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 2010;285:26558-69
   PubMed Web of Science ®Google Scholar
• Chan DK, Miskimins WK. Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. J Ovarian Res 2012;5:19
   PubMedGoogle Scholar
• Minarini A, Milelli A, Tumiatti V, et al. Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality. Eur J Med Chem 2012;48:124-31
   PubMed Web of Science ®Google Scholar
• Kim JH, Xu C, Keum YS, et al. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 2006;27:475-82
   PubMed Web of Science ®Google Scholar
• Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-5
   PubMed Web of Science ®Google Scholar
• Hecht SS, Chung FL, Richie JP Jr, et al. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 1995;4:877-84
   PubMed Web of Science ®Google Scholar
• Wang X, Di Pasqua AJ, Govind S, et al. Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J Med Chem 2011;54:809-16
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR; Washington DC: 2007
   Google Scholar
• Ogawa K, Hirose M, Sugiura S, et al. Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis. Nutr Cancer 2001;40:134-9
   PubMed Web of Science ®Google Scholar
• Jiang T, Chen N, Zhao F, et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 2010;70:5486-96
   PubMedGoogle Scholar
• Slocum SL, Kensler TW. Nrf2: control of sensitivity to carcinogens. Arch Toxicol 2011;85:273-84
   PubMed Web of Science ®Google Scholar